NIH-funded research R21 grant

Investigating how RNA modifications affect the immune response to a common intestinal parasite in children with AIDS

Official title: m6A methylation of IRGM transcripts in epithelial-Cryptosporidium interactions

Funded at Rush University Medical Center · NIH-11035212 · Data updated 2026-11-12

This study is looking at how a special change in RNA affects how our gut cells respond to a parasite that causes bad diarrhea, especially in kids and people with weakened immune systems, to find new ways to help treat these infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startFebruary 14, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$191,575
NIH project number5R21AI177188-02
Project IDNIH-11035212 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children under 11 years old and individuals with AIDS who are at risk of Cryptosporidium infections.

Less likely to help

Patients who are not affected by AIDS or do not have Cryptosporidium infections may not benefit from this research.

What this research studies

This research focuses on understanding how a specific RNA modification, known as m6A methylation, influences the immune response of intestinal cells to Cryptosporidium, a parasite that causes severe diarrhea, particularly in children and AIDS patients. The study aims to explore the molecular mechanisms by which these RNA modifications regulate the production of immune-related proteins that help fight the infection. By examining how these processes change during infection, the research seeks to identify potential targets for improving treatment strategies against this opportunistic pathogen.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance the immune response in children and AIDS patients suffering from Cryptosporidium infections.

How similar studies have gone: Previous research has shown promising results in understanding RNA modifications and their role in immune responses, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Chen, Xian-Ming — Rush University Medical Center
  • Study coordinator: Chen, Xian-Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.